including the sought-after PG Diploma in Clinical Research, ensure that our students are well-prepared to drive the complex terrain of clinical trials. In this article, we will decode the phases of ...

KaliVir Immunotherapeutics has dosed the first subject in a Phase I/Ib clinical trial for its new oncolytic immunotherapy, ...

Yufei Liu, MD, PhD, discussed the importance of careful data interpretation to accurately assess the efficacy of new ...

The vaccine demonstrated efficacy across different respiratory syncytial virus (RSV) subtypes in older adults between the ...

CLD-101 is a novel stem cell-based treatment that delivers oncolytic viruses to tumors, which may benefit patients with newly ...

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...

Learn how dupilumab significantly improves quality of life in COPD patients with type 2 inflammation, according to phase 3 ...

Genentech announced positive results from the Phase III study (REGENCY) of Gazyva (Obinutuzumab) for people with active lupus nephritis (LN).

The investigational IL-17A inhibitor izokibep was found to induce clear clinical responses in people with moderate to severe ...

Parexel, one of the world’s largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical development services, today announced it has been awarded the 2024 Society ...

The Phase 2 clinical trial is an open-label, pilot efficacy study and exploratory evaluation of the systemic bioavailability ...